CLIP3

CLIP3 (CLIPR-59) is a CAP-Gly domain-containing scaffold protein that couples membrane microdomains to the microtubule cytoskeleton and to signaling complexes governing glucose metabolism, apoptosis, and muscle/neuromuscular development (PMID:11854307, PMID:19139280). Membrane targeting is conferred by its C-terminal 30 residues, two cysteines (Cys534/535) within which are palmitoylated by the palmitoyltransferase DHHC17, anchoring CLIP3 to the trans-Golgi network and to plasma-membrane lipid rafts (PMID:11854307, PMID:15262990, PMID:24001771); unlike CLIP-170, its microtubule-binding domain preferentially engages unpolymerized tubulin and exerts an anti-polymerization activity (PMID:15262990). In insulin signaling, CLIP3 uses its CAP-Gly domain to bind the Akt kinase domain and recruit active Akt to the plasma membrane, while its ankyrin-repeat domain binds AS160, positioning Akt to phosphorylate AS160 and drive GLUT4 translocation and glucose uptake; DHHC17-dependent palmitoylation is required for this membrane-based assembly (PMID:19139280, PMID:22689584, PMID:24001771). CLIP3 also acts as a TNFR1 adaptor that, through association with the deubiquitinase CYLD, controls K63-linked RIP1 ubiquitination to promote Complex-II formation, caspase-8 activation, and TNF-α-induced apoptosis (PMID:22297296), and it chaperones the ganglioside GD3–microtubule interaction during CD95/Fas-triggered apoptosis (PMID:20052288). In muscle, CLIP3 binds Elmo2 to enhance Rac1 activation and promote myoblast fusion (PMID:25572395), and Clipr-59 knockout mice die perinatally from neuromuscular junction instability, establishing a requirement for CLIP3 in motor axon maintenance at the NMJ (PMID:23482493). CLIP3 expression and activity are regulated by Spy1, METTL3-mediated m6A modification of its 3'-UTR, and miR-147-5p (PMID:26017671, PMID:37088945, PMID:38756701).

1. 2002 Medium

   Establishing whether a CLIP-170-related protein could be membrane-associated, this work identified CLIPR-59 as a TGN-localized protein with a discrete C-terminal Golgi-targeting domain, the first membrane-targeting module in this protein family.

   Evidence Domain truncation/deletion constructs and immunofluorescence in HeLa cells

   PMID:11854307

   Open questions at the time

   • Mechanism of TGN targeting not defined at residue level
   • Functional consequence of endosome-TGN perturbation unclear
   • No endogenous partners identified
2. 2004 High

   To explain membrane anchoring, palmitoylation of two C-terminal cysteines was shown to drive lipid-raft association, and the microtubule-binding domain was found to favor unpolymerized tubulin and inhibit polymerization, distinguishing CLIPR-59 functionally from CLIP-170.

   Evidence Palmitoylation assay, lipid raft fractionation, in vitro tubulin binding, and microtubule regrowth assay

   PMID:15262990

   Open questions at the time

   • Palmitoyltransferase not yet identified
   • Physiological role of anti-polymerization activity unknown
   • Link between raft localization and cellular function untested
3. 2009 High

   Addressing how CLIPR-59 affects metabolism, it was shown to bind active Akt via its CAP-Gly domain and recruit it to the plasma membrane, redirecting Akt substrate phosphorylation to enhance adipocyte glucose transport.

   Evidence Reciprocal Co-IP, domain mapping, gain/loss-of-function in 3T3-L1 adipocytes with glucose transport readout

   PMID:19139280

   Open questions at the time

   • How Akt compartmentalization selectively favors AS160 not fully resolved
   • In vivo relevance not yet tested
   • Structural basis of CAP-Gly–kinase domain interaction unknown
4. 2010 High

   Extending CLIPR-59 beyond metabolism, it was identified as a chaperone linking ganglioside GD3 to microtubules during CD95/Fas apoptosis, enabling GD3 trafficking toward mitochondria.

   Evidence FRET, immunoelectron microscopy, siRNA knockdown in lymphoblastoid T cells

   PMID:20052288

   Open questions at the time

   • Direct GD3-binding interface on CLIPR-59 undefined
   • Connection to other apoptotic roles unclear
5. 2012 High

   Two studies refined the apoptotic and metabolic roles: CLIPR-59 was shown to be a TNFR1 adaptor controlling RIP1 ubiquitination via CYLD to promote apoptosis, and to bind AS160 through its ankyrin repeats to enable Akt-dependent GLUT4 translocation.

   Evidence Reciprocal Co-IP, domain-deletion mutants, ubiquitination and caspase assays; GLUT4 translocation assays in 3T3-L1 adipocytes

   PMID:22297296 PMID:22689584

   Open questions at the time

   • How CLIPR-59 coordinates CYLD recruitment with TNFR1 dissociation unresolved
   • Whether scaffolding roles in apoptosis and metabolism are simultaneous or context-specific
6. 2013 High

   The palmitoylation enzyme and the organismal requirement were established: DHHC17 was identified as the palmitoyltransferase modifying Cys534/535 to drive membrane/Akt localization, and Clipr-59 knockout mice revealed an essential role in neuromuscular junction stability and survival.

   Evidence DHHC screen with site-directed mutagenesis and adipocyte GLUT4 assays; constitutive knockout mouse with electrophysiology, EM, and histology

   PMID:23482493 PMID:24001771

   Open questions at the time

   • Molecular pathway linking CLIPR-59 to NMJ maintenance unknown
   • Whether NMJ role depends on palmitoylation or known partners untested
7. 2015 Medium

   Further roles in muscle and metabolism emerged: CLIPR-59 binds Elmo2 to activate Rac1 and promote myoblast fusion, Spy1 antagonizes CLIPR-59–CYLD-mediated apoptosis in glioblastoma, and adipose-specific overexpression improves whole-body glucose homeostasis and adiponectin secretion.

   Evidence Yeast two-hybrid, Co-IP, Rac1 pulldown, C2C12 fusion assays; Co-IP and ubiquitination assays in GBM cells; adipose-specific transgenic mice with metabolic phenotyping

   PMID:25572395 PMID:26017671 PMID:26451285

   Open questions at the time

   • Mechanism linking ClipR-59 overexpression to AMPKα phosphorylation not dissected
   • Whether Spy1 regulation operates in non-tumor contexts unknown
8. 2021 Medium

   Linking CLIP3 to tumor metabolism, Spy1-driven downregulation of CLIP3 was shown to promote GLUT3 trafficking and glycolytic reprogramming in radioresistant glioblastoma stem cells, with CLIP3 restoration suppressing tumor growth.

   Evidence Metabolic flux assays, live-cell imaging, orthotopic xenografts in patient-derived GSCs

   PMID:34488821

   Open questions at the time

   • Direct mechanism of CLIP3 control over GLUT3 trafficking not fully defined
   • Transcriptional mechanism of Spy1-mediated CLIP3 repression unclear
9. 2023 Medium

   Post-transcriptional control was established: METTL3-mediated m6A modification of the CLIP3 3'-UTR enhances mRNA degradation and lowers protein levels, linking CLIP3 regulation to radiation-induced bone injury.

   Evidence m6A-seq, dual-luciferase reporter, METTL3 gain/loss-of-function in irradiated BMSCs

   PMID:37088945

   Open questions at the time

   • m6A reader mediating degradation not identified
   • Downstream CLIP3 effectors in bone cells undefined
10. 2024 Medium

    An additional regulatory and immune role was defined: miR-147-5p directly targets the CLIP3 3'-UTR, and CLIP3 acts as a negative regulator of Th17 differentiation downstream of this miRNA.

    Evidence Dual-luciferase reporter, miRNA mimics, CLIP3 overexpression rescue, flow cytometry in CD4+ T cells

    PMID:38756701

    Open questions at the time

    • Molecular mechanism by which CLIP3 restrains Th17 differentiation unknown
    • In vivo immune relevance untested

• How CLIP3's distinct scaffolding roles (Akt/AS160, TNFR1/CYLD, Elmo2/Rac1, GD3/microtubule) are coordinated within a single protein, and whether palmitoylation/microtubule binding gate selection among them, remains unresolved.
• No structural model of the multidomain protein or its complexes
• Tissue-specific determinants of which partner network operates are undefined
• Whether the NMJ phenotype reflects a known signaling axis is unknown